Maximus (NYSE:MMS) Shares Gap Down – Time to Sell?

Posted by Teresa Graham on Nov 9th, 2026

Maximus, Inc. (NYSE:MMS – Get Free Report) gapped down prior to trading on Monday. The stock had previously closed at $69.22, but opened at $65.64. Maximus shares last traded at $65.5410, with a volume of 14,103 shares.

Analysts Set New Price Targets

MMS has been the topic of several recent research reports. Zacks Research upgraded Maximus from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 1st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Maximus in a research note on Monday, August 17th. Finally, Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Two investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, Maximus presently has an average rating of “Hold”.

Read Our Latest Research Report on Maximus

Maximus Price Performance

The stock has a market capitalization of $3.42 billion, a PE ratio of 9.64 and a beta of 0.56. The company has a current ratio of 2.42, a quick ratio of 2.42 and a debt-to-equity ratio of 0.90. The company’s 50 day simple moving average is $58.76 and its 200 day simple moving average is $64.38.

Maximus (NYSE:MMS – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, beating the consensus estimate of $2.21 by $0.01. Maximus had a return on equity of 24.91% and a net margin of 7.07%. The company had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the previous year, the firm posted $2.16 EPS. Maximus’s revenue was down 5.1% on a year-over-year basis. On average, equities analysts anticipate that Maximus, Inc. will post 8.03 earnings per share for the current year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Friday, November 13th will be issued a dividend of $0.33 per share. The ex-dividend date is Friday, November 13th. This represents a $1.32 annualized dividend and a dividend yield of 2.0%. Maximus’s dividend payout ratio (DPR) is 19.50%.

Insider Activity at Maximus

In other news, insider Michelle Link sold 3,208 shares of Maximus stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $54.23, for a total value of $173,969.84. Following the completion of the sale, the insider owned 13,881 shares of the company’s stock, valued at $752,766.63. The trade was a 18.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.80% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Maximus

Several large investors have recently added to or reduced their stakes in MMS. Nisa Investment Advisors LLC grew its holdings in Maximus by 0.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 31,919 shares of the health services provider’s stock valued at $1,698,000 after buying an additional 195 shares during the period. Allworth Financial LP increased its stake in shares of Maximus by 60.8% during the 3rd quarter. Allworth Financial LP now owns 645 shares of the health services provider’s stock valued at $35,000 after acquiring an additional 244 shares during the last quarter. QRG Capital Management Inc. increased its stake in shares of Maximus by 9.3% during the 1st quarter. QRG Capital Management Inc. now owns 3,240 shares of the health services provider’s stock valued at $208,000 after acquiring an additional 277 shares during the last quarter. Root Financial Partners LLC acquired a new position in shares of Maximus during the 3rd quarter valued at about $26,000. Finally, Covestor Ltd lifted its holdings in shares of Maximus by 33.2% during the 3rd quarter. Covestor Ltd now owns 2,199 shares of the health services provider’s stock worth $117,000 after acquiring an additional 548 shares during the period. 97.21% of the stock is currently owned by hedge funds and other institutional investors.